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Abstract   
Introduction: Pulpotomy of carious primary teeth with an exposed pulp is a common 
treatment option. Pulpotomy has been conducted with various medicaments over the years. The 
aim of this study was to evaluate clinical and radiographic success of primary vital pulpotomy 
with ProRoot and Root MTA. 
Materials and Methods: In this randomized clinical trial, children aged between 3-7 
years who met the inclusion criteria were enrolled. A total of 70 teeth were deemed suitable 
under the inclusion criteria and teeth were randomly divided into the 2 groups; ProRoot and 
Root MTA. Pulpotomy was performed and immediately followed by coronal amalgam 
restoration. The clinical and radiographic follow ups were conducted 6, 12, 18, 30 months post-
operatively. The data were analyzed using Exact Fisher test.  
Results: : At the final follow up, 28 teeth in ProRoot MTA and 26 teeth in Root MTA were 
evaluated. In the Root MTA group, 1 tooth had exfoliated and one had an abscess and furcal 
radiolucency radiographically. In ProRoot MTA group, external resorption was observed in 1 
tooth. Statistical analysis did not show significant difference in success rate between 2 groups 
after 30 months. 
Conclusion: The success rates of Root and ProRoot MTA are similar, indicating that 
pulpotomy can be carried out successfully in both primary molars. [Iranian Endodontic Journal 
2010;5(4):157-60] 
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Introduction 
The objective of pulpotomy treatment of a 
primary molar is to preserve the tooth until 
natural exfoliation and eruption of permanent 
successor occurs. Pulpotomy treatment consists 
of coronal pulp removal, placement of 
medicament and the final permanent restoration 
(1,2). Several agents have been used in 
pulpotomy, including formecresol and mineral 
trioxide aggregate (MTA) (3-7). MTA was 
introduced by Torabinejad and is composed of 
tricalcium silicate, tricalcium aluminate and 
tricalcium oxide and silicate oxide. Hydration 
of MTA produces a colloidal gel that sets 
gradually as the pH reaches 12 (1,2). MTA has 
low cytotoxicity, good biocompatibility (3) and 
is also antibacterial to a degree. Furthermore, it 
can preserve tissue integrity more than calcium 
hydroxide (8-10) and can induce hard tissue 
formation (8,11-13). These characteristics 
make MTA a suitable material for pulpotomy 
(8-15). Success rates of pulpotomy with MTA 
have been evaluated in several studies. Some 
studies suggest that there is no significant 
difference between success rate of MTA and 
formecresol, though others have caused 
controversy by suggesting either higher success 
rates for MTA or formecresol (16-19). Root 
MTA has been introduced (Tabriz, Iran) as an 
alternative to ProRoot MTA and showed similar 
characteristics to ProRoot MTA in histological 
and in vitro studies. These studies revealed that 
the cytotoxicity of Root MTA on L929 is less 
than ProRoot MTA (20) and that there are no 
significant difference between Root MTA, 
ProRoot MTA and Portland cement when 
evaluating tissue inflammatory response, 
fibrous capsule and bone formation (21). 
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Table1: Radiographic signs 30 months after 
pulpotomy with Root MTA and ProRoot MTA 
 
*IR: Internal resorption, ER: External resorption, FR: Furcal 
radiolucency 
 
Results of a further clinical study revealed that 
the difference in success rate of pulpotomy 
with Root MTA, ProRoot MTA after 12 
months is not statistically significant (22).  
The aim of this study was to compare the long 
term clinical and radiographic success rate of 
pulpotomy with Root MTA and ProRoot MTA. 
 
Materials and Methods 
This randomized clinical trial was performed 
on children who were referred to pediatric 
department of Shahed Dental School for dental 
treatment. Inclusion criteria for subjects were 1) 
age range of 3-7 years; 2) primary molar in need 
of pulpotomy; 3) healthy systemic status with no 
contraindication for pulpotomy; 4) carious 
primary molar teeth that required pulpotomy. 
Written informed consent was obtained from 
their parents. The clinical criteria for tooth 
selection were 1) no clinical symptoms such as 
spontaneous pain during the night; 2) no 
tenderness to pressure/percussion; 3) no 
mobility; 4) absence of associated swelling or 
sinus tract; 5) absence of vital carious pulp 
exposure on examination; and 6) presence of 
restorable crowns. Radiographic criteria 
included the absence of: 1) internal and external 
resorption; 2) furcal radiolucency; and 3) root 
canal calcifications. Seventy teeth, in accordance 
with similar studies (6,15,22), that met the 
inclusion criteria were randomly allocated in 
either Root MTA (Tabriz, Iran) or ProRoot 
MTA (DENTSPLY Tulsa), (ProRoot group 
code 0, Root MTA group code 1). Randomized 
allocation was conducted by dental assistant 
who was blinded to the study design. The 
primary tooth pulpotomies were performed by 
the same pedodontist throughout the study. After 
anesthesia, caries was removed and coronal 
access was made with a #245 bur (Dentsply 
Maillefer, Tulsa, OK, USA) and high speed 
hand piece. Coronal pulp was removed with a 
spoon excavator; subsequently, the pulp 
chamber was irrigated with saline. Hemorrhage 
was controlled by placing a cotton pellet 
moistened in saline with slight pressure. Once 
hemostasis was achieved in both groups the 
material were mixed according to instructions 
and placed within the pulp chamber. All teeth 
were restored with amalgam and examined after 
6, 12, 18 and 30 months clinically and 
radiographically by a blind dentist. Clinical and 
radiographic success criteria were as follows: 1) 
the absence of pain, mobility, swelling, and 
sinus tract; and 2) radiographic absence of 
internal and external resorption and furcal 
radiolucency (23-25). The presence of even 
single clinical and/or radiographic failure 
rendered the treatment as a failure. Data were 
analyzed using Fisher Exact test.  
 
Results  
At the 6 month post-operative evaluation, 34 
teeth in Root MTA group and 33 teeth in 
ProRoot MTA group were examined. No 
failure was observed in the 6-month samples. 
In the 12 months follow up, 31 teeth in ProRoot 
and 31 teeth in Root MTA group were 
evaluated. In Root MTA group, all the cases 
showed successful results. In ProRoot MTA 
group, two failures were observed including an 
abscess and furcal radiolucency. Fisher Exact 
test revealed no statistically difference in success 
rate between ProRoot and Root MTA. The 
18month follow up was performed on 30 cases 
in ProRoot MTA and 31 cases in Root MTA 
group which were all successful. During the 30 
months post operative evaluation, 28 teeth in 
ProRoot MTA and 26 teeth in Root MTA 
groups were available for assessment. In the 
Root MTA group, one tooth exfoliated and one 
demonstrated abscess and furcal radiolucency 
(as well as canal calcification which impeded 
pulpectomy treatment) at the 30 month follow 
up evaluation (Table 1,2). In ProRoot MTA 
external resorption was seen in 1 tooth; the 




Pulpotomy is a common modality in primary 
teeth with carious exposed pulp. This procedure 
preserves the tooth and also the arch space for 
permanent teeth; thereby it avoids future 
problems (26,27). Formecresol is  the  common 
medicament in pulpotomy; it has some distinct  
                Signs 
Materials N IR ER FR 
Root MTA 26 0 0 1(3.8%) 
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Table 2: Clinical signs 30 months after pulpotomy with Root MTA and ProRoot 
 
Clinical signs Pain Swelling Mobility Sinus tract Tenderness to percussion Abscess 
Root MTA(26) 0 0 0 0 0 1(3.8%) 
ProRoot MTA(28) 0 0 0 0 0 0 
 
disadvantages such as cytotoxicity and potential 
of mutagenicity and carcinogenicity. (28,29). 
MTA is biocompatible and antibacterial 
material with little cytotoxicity. Moreover, it 
induces cell proliferation and regeneration (3-
5,8-9), and has been proposed as a suitable 
medicament for pulpotomy. Root MTA has 
been produced in Iran and has the same 
favorable characteristics of ProRoot MTA (20-
22). In this study, we evaluated the long-term 
success rate of pulpotomy of primary molars 
with Root MTA and ProRoot MTA. Results of 
this study showed high radiographic (Root 
MTA=96.16% and ProRoot MTA=100%) and 
clinical (Root MTA=96.16% ProRoot 
MTA=96.43%) success. The difference between 
two materials was not statistically significant. 
Ramezankhani et al. and Sadre Lahigani's et al. 
demonstrated that the inflammation and 
biocompatibility of ProRoot MTA and Root 
MTA was not different, possibly due to their 
similar characteristics and composition (21,30). 
A previous study reported 100% clinical and 
radiographic success rates for pulpotomy with 
Root MTA and 96.78% success rates for 
pulpotomy with ProRoot MTA after 1 year, 
concurring with our study (22); however, our 
study consisted of longer follow up period. 
Only one tooth demonstrated periapical 
infection and root canal calcification impeding 
further treatment in the present study. This may 
only pose a problem to treatment outcome if a 
significant percentage of pulpotomized primary 
teeth demonstrated root calcifications and 
associated abscesses following treatment.  
In this study, clinical and radiographic success 




ProRoot MTA and Root MTA can be considered 
as suitable materials for pulpotomy of primary 
molars. Further studies can address and compare 
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